The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1560 · Cited by 1,200
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Advanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Pericytes and the Pathogenesis of Diabetic Retinopathy
Hammes, H.-P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., & Deutsch, U. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3107 · Cited by 665
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Bierhaus, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00233-2 · Cited by 555
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Schröder, S., Palinski, W., & Schmid‐Schönbein, G. W. (1991) · PubMed Central · Cited by 479
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Self-citationMonnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Yamagishi, S.-I., & Imaizumi, T. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054367300 · Cited by 452
Self-citationDE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Tanaka, N., Yonekura, H., Yamagishi, S.-I., Fujimori, H., Yamamoto, Y., & Yamamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001235200 · Cited by 424
Self-citationURIBARRI, J., CAI, W., SANDU, O., PEPPA, M., GOLDBERG, T., & VLASSARA, H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.052 · Cited by 423
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 413
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 367
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Yamagishi, S.-I., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 310
Self-citationNomura, M., Yamagishi, S.-I., Harada, S.-I., Hayashi, Y., Yamashima, T., Yamashita, J., & Yamamoto, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28316 · Cited by 297
Self-citationAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Stern, D., Du Yan, S., Fang Yan, S., & Marie Schmidt, A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00160-6 · Cited by 281
Advanced Glycation End Products-driven Angiogenesis in Vitro
Yamagishi, S.-I., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8723 · Cited by 276
Self-citationPossible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 267
Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Koga, K., Abe, R., Takeuchi, M., Ohno, S., Yoshimura, A., & Makita, Z. (2002) · The FASEB Journal · doi:10.1096/fj.02-0030fje · Cited by 258
Self-citationSUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Antimicrobial Activity of Coffee Melanoidins—A Study of Their Metal-Chelating Properties
Rufián-Henares, J. A., & de la Cueva, S. P. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8027842 · Cited by 245
VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Kowluru, R. A., & Odenbach, S. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3233 · Cited by 227
AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction
Fukami, K., Ueda, S., Yamagishi, S.-I., Kato, S., Inagaki, Y., Takeuchi, M., Motomiya, Y., Bucala, R., Iida, S., Tamaki, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66004.x · Cited by 218
Self-citationYamagishi, S.-I., Nakamura, K., Matsui, T., Inagaki, Y., Takenaka, K., Jinnouchi, Y., Yoshida, Y., Matsuura, T., Narama, I., Motomiya, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602110200 · Cited by 217
Self-citationYamagishi, S.-I., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 209
Self-citationAdvanced Glycation in Health and Disease: Role of the Modern Environment
VLASSARA, H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.051 · Cited by 207
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 206
Vascular Endothelial Growth Factor Plays a Role in Hyperpermeability of Diabetic Retinal Vessels
Murata, T., Ishibashi, T., Khalil, A., Hata, Y., Yoshikawa, H., & Inomata, H. (1995) · Ophthalmic Research · doi:10.1159/000267567 · Cited by 199
Uribarri, J., Peppa, M., Cai, W., Goldberg, T., Lu, M., Baliga, S., Vassalotti, J. A., & Vlassara, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00779-0 · Cited by 197
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 194
Self-citationHe, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Cai, W., He, J. C., Zhu, L., Chen, X., Zheng, F., Striker, G. E., & Vlassara, H. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080152 · Cited by 186
Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
PUGLIESE, G., PRICCI, F., IACOBINI, C., LETO, G., AMADIO, L., BARSOTTI, P., FRIGERI, L., HSU, D. K., VLASSARA, H., LIU, F.-T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 184
Cai, W., He, J. C., Zhu, L., Peppa, M., Lu, C., Uribarri, J., & Vlassara, H. (2004) · Circulation · doi:10.1161/01.cir.0000135587.92455.0d · Cited by 177
Reiniger, N., Lau, K., McCalla, D., Eby, B., Cheng, B., Lu, Y., Qu, W., Quadri, N., Ananthakrishnan, R., Furmansky, M., et al. (2010) · Diabetes · doi:10.2337/db09-1766 · Cited by 177
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet
Cai, W., He, J. C., Zhu, L., Chen, X., Wallenstein, S., Striker, G. E., & Vlassara, H. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061281 · Cited by 175
Ishibashi, Y., Matsui, T., Takeuchi, M., & Yamagishi, S.-I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.075 · Cited by 173
Self-citationThe Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Moore, T. C. B., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B., et al. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1063 · Cited by 172
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 171
Yamagishi, S.-I., Inagaki, Y., Amano, S., Okamoto, T., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00940-3 · Cited by 171
Self-citationMiura, J., Yamagishi, S., Uchigata, Y., Takeuchi, M., Yamamoto, H., Makita, Z., & Iwamoto, Y. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00183-6 · Cited by 170
Self-citationYamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., & Takeuchi, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00752.x · Cited by 165
Self-citationCai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600362103 · Cited by 163
Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention
Yamagishi, S., Fukami, K., Ueda, S., & Okuda, S. (2007) · Current Drug Targets · doi:10.2174/138945007781386884 · Cited by 151
Self-citationVascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Kim, N. H., Oh, J. H., Seo, J. A., Lee, K. W., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Kang, Y. S., Han, S. Y., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00067.x · Cited by 147
Bucala, R., Mitchell, R., Arnold, K. S., Innerarity, T. L., Vlassara, H., & Cerami, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10828 · Cited by 147
Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.983 · Cited by 145
Self-citationOn the Pathogenesis of Diabetic Retinopathy
Frank, R. N. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32253-x · Cited by 133
Takeuchi, M., & Yamagishi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0974 · Cited by 129
Self-citationYamagishi, S., Ueda, S., & Okuda, S. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781757051 · Cited by 128
Self-citationSemba, R. D., Ferrucci, L., Sun, K., Beck, J., Dalal, M., Varadhan, R., Walston, J. D., Guralnik, J. M., & Fried, L. P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03325227 · Cited by 120
Inagaki, Y., Yamagishi, S., Okamoto, T., Takeuchi, M., & Amano, S. (2003) · Diabetologia · doi:10.1007/s00125-002-1013-4 · Cited by 119
Self-citationAdvanced Glycation Endproducts Accelerate Calcification in Microvascular Pericytes
Yamagishi, S., Fujimori, H., Yonekura, H., Tanaka, N., & Yamamoto, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0625 · Cited by 107
Self-citationTagliazucchi, D., Verzelloni, E., & Conte, A. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903701h · Cited by 105
Yamagishi, S., Nakamura, K., Matsui, T., Noda, Y., & Imaizumi, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597416 · Cited by 104
Self-citationChen, Q., Dong, L., Wang, L., Kang, L., & Xu, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.040 · Cited by 103
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Chiarelli, F., Cipollone, F., Mohn, A., Marini, M., Iezzi, A., Fazia, M. L., Tumini, S., Cesare, D. D., Pomilio, M., Pierdomenico, S. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1829 · Cited by 90
Shaw, S., Schmidt, A. M., Banes, A. K., Wang, X., Stern, D. M., & Marrero, M. B. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2381 · Cited by 83
Galler, A., Müller, G., Schinzel, R., Kratzsch, J., Kieß, W., & Münch, G. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2609 · Cited by 82
Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Takenaka, K., Yamagishi, S., Matsui, T., Nakamura, K., & Imaizumi, T. (2006) · Current Neurovascular Research · doi:10.2174/156720206775541804 · Cited by 77
Self-citationHoenig, M., Bianchi, C. F., Rosenzweig, A., & Sellke, F. W. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733685 · Cited by 74
Upregulation of CD40–CD40 ligand system in patients with diabetes mellitus
Jinchuan, Y., Wu, Z., Jinming, C., Li, L., & Xiantao, K. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.09.007 · Cited by 68
Schrijvers, B. F., Flyvbjerg, A., Tilton, R. G., Lameire, N. H., & Vriese, A. S. D. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi217 · Cited by 65
FOXO1 plays an essential role in apoptosis of retinal pericytes.
Alikhani, M., Roy, S., & Graves, D. T. (2010) · PubMed Central · Cited by 63
Torreggiani, M., Liu, H., Wu, J. C., Zheng, F., Cai, W., Striker, G. E., & Vlassara, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090138 · Cited by 62
Bhatwadekar, A. D., Glenn, J. V., Li, G., Curtis, T. M., Gardiner, T. A., & Stitt, A. W. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1015 · Cited by 62
Yamagishi, S., Matsui, T., Nakamura, K., Inoue, H., Takeuchi, M., Ueda, S., Okuda, S., & Imaizumi, T. (2007) · Ophthalmic Research · doi:10.1159/000111152 · Cited by 60
Self-citationSemba, R. D., Fink, J. C., Sun, K., Windham, B. G., & Ferrucci, L. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.08.001 · Cited by 60
Scheubel, R. J., Kahrstedt, S., WEBER, H., Holtz, J., Friedrich, I., Börgermann, J., Silber, R., & Simm, A. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.002 · Cited by 55
Increased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin Vitro
Hangaishi, M., Taguchi, J., Miyata, T., Ikari, Y., Togo, M., Hashimoto, Y., Watanabe, T., Kimura, S., Kurokawa, K., & Ohno, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8945 · Cited by 54
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro
Okamoto, T., Yamagishi, S., Inagaki, Y., Amano, S., Takeuchi, M., Kikuchi, S., Ohno, S., & Yoshimura, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02218-0 · Cited by 52
Self-citationUeno, H., Koyama, H., Fukumoto, S., Tanaka, S., Shoji, T., Shoji, T., Emoto, M., Tahara, H., Inaba, M., Kakiya, R., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.001 · Cited by 48
Semba, R. D., Fink, J. C., Sun, K., Bandinelli, S., Guralnik, J. M., & Ferrucci, L. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0757-0 · Cited by 48
Yamagishi, S., Amano, S., Inagaki, Y., Okamoto, T., Takeuchi, M., & Makita, Z. (2002) · Molecular Medicine · doi:10.1007/bf03402164 · Cited by 45
Self-citationChen, J., Huang, L. J., Song, M., Yu, S., Gao, P., & Jing, J. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31819b5438 · Cited by 42
Zoltowska, M., DELVIN, E. E., Ziv, E., et al. (2004) · Lipids · doi:10.1007/s11745-004-1205-7 · Cited by 23
Cited by
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Moldogazieva, N. T., Mokhosoev, I. M., Mel’nikova, T. I., Porozov, Y. B., & Terentiev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3085756 · Cited by 493
Schiff Bases: A Short Survey on an Evergreen Chemistry Tool
Qin, W., Long, S., Panunzio, M., & Biondi, S. (2013) · Molecules · doi:10.3390/molecules181012264 · Cited by 408
Sorghum (Sorghum bicolor L.): Nutrients, bioactive compounds, and potential impact on human health
de Morais Cardoso, L., Pinheiro, S. S., Martino, H. S. D., & Pinheiro-Sant'Ana, H. M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.887057 · Cited by 379
Metadata
- Authors
- Yamagishi, S.-I.
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 46
- Issue
- 4
- Pages
- 217-224
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W2023497842
- Cited by
- 302
- References
- 107
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.